SR
CVS icon

Syntax Research’s CVS Health CVS Stock Holding History

Syntax Research’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Hold
203
– – 0.02% 121
2026
Q1 		$14.6K Sell
203
-168
-45% -$12.9K 0.01% 137
2025
Q4 		$29.4K Hold
371
– – 0.02% 109
2025
Q3 		$28K Hold
371
– – 0.02% 109
2025
Q2 		$25.6K Hold
371
– – 0.02% 103
2025
Q1 		$25.1K Sell
371
-401
-52% -$24K 0.02% 104
2024
Q4 		$34.7K Hold
772
– – 0.02% 101
2024
Q3 		$48.5K Sell
772
-155
-17% -$9.04K 0.03% 89
2024
Q2 		$54.7K Hold
927
– – 0.04% 80
2024
Q1 		$73.9K Hold
927
– – 0.06% 72
2023
Q4 		$73.2K Sell
927
-12
-1% -$854 0.06% 71
2023
Q3 		$65.6K Buy
+939
New +$66.5K 0.05% 80

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Syntax Research's CVS Position: Q2 2026 in Review

Syntax Research held its CVS Health (CVS) position steady in Q2 2026 at 203 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #121.

Syntax Research first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. The position peaked at $73.9K in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Syntax Research held 203 shares of CVS Health worth $21K as of Q2 2026.
  • Syntax Research left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.02% of Syntax Research's portfolio in Q2 2026, its #121 holding.
  • Syntax Research first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
  • Syntax Research's CVS Health position peaked at $73.9K in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.